Abortion Pill Sellers Put Women’s Lives at Risk by Violating FDA Safety Limits

A new Charlotte Lozier Institute (CLI) report discovered many online abortion drug sellers are violating U.S. laws, exceeding FDA safety limits, and selling unapproved and misbranded drugs to U.S. consumers. This blatant disregard for the law was only boosted by the removal of the in-person dispensing requirement in 2021. The report identifies these violations across online sellers operating outside of the U.S. healthcare system as well as the violations committed by online abortion drug sellers